PKM2 promotes glioma progression by mediating CTNNB1 expression.
Chunyang MaYuan FengKaiyi ZhongJiali Wei
Published in: Neurological research (2024)
In summary, these findings indicated that PKM2 promotes glioma progression by mediating CTNNB1 expression, providing a possible molecular marker for the clinical management of gliomas.